ライフサイエンスコーパス: mastitis

1 tally induced Staphylococcus aureus clinical mastitis.

2 tools to identify S. aureus CC during bovine mastitis.

3 ctiae, one of the causative agents of bovine mastitis.

4 ntributing to higher milk viral loads during mastitis.

5 site detection and field diagnosis of bovine mastitis.

6 ient previously diagnosed with granulomatous mastitis.

7 ads in breast milk were not increased during mastitis.

8 ical processes that occur during LPS-induced mastitis.

9 ontribute to milk composition changes during mastitis.

10 hanisms affected in cows more susceptible to mastitis.

11 3.3, 95% CI: 1.92, 5.62) strongly predicted mastitis.

12 uarters suffering recurrent cases of E. coli mastitis.

13 (CoNS) from bovine clinical and subclinical mastitis.

14 subspecies zooepidemicus, a cause of bovine mastitis.

15 f early inflammatory responses during bovine mastitis.

16 amammary therapy for the treatment of bovine mastitis.

17 as up-regulated on leukocytes from cows with mastitis.

18 were studied during Escherichia coli-induced mastitis.

19 7, a serum-resistant isolate from a cow with mastitis.

20 ssociations with clinical characteristics of mastitis.

21 tory pathways involved in the development of mastitis.

22 reducing ROS production in S aureus-induced mastitis.

23 ate immune cell responders during infectious mastitis.

24 ing for on-site pathogen detection of bovine mastitis.

25 ing of the molecular interactome involved in mastitis.

26 ductal mastitis and idiopathic granulomatous mastitis.

27 d modules associated with clinical traits of mastitis.

28 NAs as early diagnostic biomarkers of bovine mastitis.

29 were found in Egyptian cattle suffering from mastitis.

30 (based on HMO profile) was not associated to mastitis.

31 cular diagnosis and biological therapies for mastitis.

32 oblotting, with a stronger reactivity in SAU mastitis.

33 ntly influence the pathophysiology of bovine mastitis.

34 m dairy cattle with transient and persistent mastitis.

35 cells and in a mouse model of staphylococcal mastitis.

36 ent approach to treat lactational infectious mastitis.

37 the development of chronic S. aureus-related mastitis.

38 the dairy industry are used to treat bovine mastitis.

39 ays relevant to bovine S. aureus subclinical mastitis.

40 hanistic studies on susceptibility of bovine mastitis.

41 is an alga increasingly isolated from bovine mastitis.

42 lead to the development of vaccines against mastitis.

43 ysbiosis of the milk microbiome that permits mastitis.

44 rine macrophages and using a murine model of mastitis.

45 could make dairy animals more vulnerable to mastitis.

46 he azithromycin group had lower incidence of mastitis (0.3% vs 0.5%; RD, -0.24 [95% CI, -0.47 to -0.0

47 lso be used in the virgin animal with little mastitis 3 days after transduction.

48 collected from 67 cows diagnosed with bovine mastitis across 24 farms.

49 ancy to women who had experienced infectious mastitis after previous pregnancies.

50 Although the etiology and diagnosis of acute mastitis (AM) is well established, little is known about

51 -32 (IL-32) in Staphylococcus aureus-induced mastitis, an inflammation of the mammary gland, is uncle

52 inflammatory breast diseases (granulomatous mastitis and acute suppurative mastitis) and mean ADC va

53 SAM-suffering mothers, during the course of mastitis and after symptoms disappeared.

54 microbiome of milk that are associated with mastitis and antimicrobial therapy.

55 Granulomatous lobular mastitis and breast abscesses have a strong association

56 Mastitis and breast milk HIV-1 load may increase the ris

57 lococcus aureus are a common cause of bovine mastitis and can result in both clinical (CM) or subclin

58 ith the progression of S. aureus subclinical mastitis and could be used as powerful biomarkers for th

59 nd miRNAs modulate immune response in bovine mastitis and could potentially serve as disease biomarke

60 GT-II is the genotype associated with acute mastitis and decreased milk production, although its pat

61 ection of the mammary gland with necrotizing mastitis and high fever was observed for both H5N1 isola

62 ce genes complicates the treatment of bovine mastitis and highlights the serious threat to public hea

63 th peripheral and local sites of cattle with mastitis and identified important granulocyte-specific f

64 wn etiology includes the entities periductal mastitis and idiopathic granulomatous mastitis.

65 series of 9 severe gynecological infections (mastitis and pelvic cellulitis) occurring in the French

66 ein, we develop a murine model of autoimmune mastitis and provide a detailed characterization of its

67 ive understanding of the metabolic status of mastitis and provide new insights into its impact on the

68 s dysgalactiae isolated from cases of bovine mastitis and septic arthritis in lambs.

69 de causing diseases such as pleuropneumonia, mastitis and septicaemia.

70 understanding of the epidemiology of E. coli mastitis and suggest that pathogen adaptation and host s

71 ghest homology with a GBS strain causing cow mastitis and that the 1992 ST-1 strain differed from ser

72 es were collected from cows showing signs of mastitis and used for microbiological culture.

73 associated with symptomatic and asymptomatic mastitis and with the quantity of HIV-1 RNA and DNA in m

74 rial and viral infections, which can lead to mastitis and, in some cases, vertical transmission to of

75 granulomatous mastitis and acute suppurative mastitis) and mean ADC value of metastatic lymph nodes.

76 have been identified as causative agents in mastitis, and are traditionally diagnosed by bacterial c

77 ens but have so far not been associated with mastitis, and DNA of bacteria that are currently not kno

78 te immune responses, reduces the severity of mastitis, and facilitates clearance and neutralization o

79 Escherichia coli strains that caused bovine mastitis, and have since been implicated in many physiol

80 ing genital ulcer disease, chorioamnionitis, mastitis, and malnutrition in HIV-infected women, and of

81 ncluding hearing loss, orchitis, oophoritis, mastitis, and pancreatitis.

82 ity to replicate in the mammary gland, cause mastitis, and produce high viral loads in milk.

83 s pneumonia, pharyngitis, otitis, arthritis, mastitis, and reproductive disorders in cattle and bison

84 Protection against S. aureus mastitis appears to be achievable with as little as 3 mi

85 Heat stress and mastitis are major economic issues in dairy production.

86 y endemic clones of S. aureus causing bovine mastitis around the world and traced them back to 4 inde

87 cus aureus (Newbould) that developed chronic mastitis as assessed by bacteria and somatic cell counts

88 Cows diagnosed with clinical mastitis associated with Gram-negative pathogens or nega

89 notable differences in the genomes of bovine mastitis-associated and human clones of S. aureus and pr

90 omparative genomic analysis between a bovine mastitis-associated clone, RF122, and the recently seque

91 Cows diagnosed as negative for mastitis at dry off were randomly allocated to receive a

92 f 9.5% reported provider-diagnosed lactation mastitis at least once during the 12-week period, with 6

93 ss-sectional study, laboratory indicators of mastitis (breast milk sodium [Na(+)] concentration, sodi

94 Staphylococcus aureus commonly causes bovine mastitis, but bovine strains, unlike human isolates of S

95 Subclinical mastitis by Staphylococcus aureus (SAU) and by non-aureu

96 viate various inflammatory diseases, such as mastitis, by modulating immune responses.

97 e findings indicate that 38% of all clinical mastitis cases and 63% of the PTEs attributed to S. uber

98 PTE ST, represented 40% of all the clinical mastitis cases and occurred in 63% of the herds.

99 s sequences were the third most prevalent in mastitis cases diagnosed as Staphylococcus aureus by cul

100 were the second most prevalent sequences in mastitis cases diagnosed as Streptococcus dysgalactiae b

101 were the second most prevalent sequences in mastitis cases diagnosed as Trueperella pyogenes by cult

102 accounted for >50% of all S. uberis clinical mastitis cases in 33% of the herds.

103 olates of Streptococcus uberis from clinical mastitis cases in a study of 52 commercial dairy herds o

104 Forty-one percent of all clinical E. coli mastitis cases occurred in just 2.2% of the population.

105 arison between subacute (SAM) and acute (AM) mastitis cases revealed differences related to the etiol

106 S. uberis mastitis cases that occurred in different cows within th

107 y farm from recently calved cows or clinical mastitis cases were cultured, and 181 isolates were iden

108 of previous lactation and count of positive mastitis cases) to encoded MALDI-TOF spectra, which incr

109 acter, and Staphylococcus, often involved in mastitis cases, were the most abundant genera across tre

110 Mastitis caused by antibiotic-resistant strains of Staph

111 Bovine mastitis caused by S. aureus has a major economic impact

112 an anti-virulence therapy to control bovine mastitis caused by S. aureus.

113 Among all mastitis causing bacterial pathogens, Klebsiella pneumon

114 After inoculation of the MG with a mastitis-causing E. coli strain, the bacterial load incr

115 The phylogenetic analysis classified all mastitis-causing K. pneumoniae into two major phylogroup

116 r a better understanding of the virulence of mastitis-causing K. pneumoniae strains and may lead to t

117 Staphylococcus aureus is a major mastitis-causing pathogen in cattle.

118 Thus, we concluded P. zopfii GT-II is a mastitis-causing pathogen that triggers severe inflammat

119 irst lysin that kills all four of the bovine mastitis-causing pathogens.

120 he E. coli P4 were submitted to a homologous mastitis challenge.

121 itis, we compared the microbiome of clinical mastitis (CM, n = 14) and healthy (H, n = 7) milk sample

122 ount in milk of cows with S. aureus clinical mastitis compared to untreated cows.

123 Bovine mastitis continues to be the most detrimental factor for

124 f E. coli are of great importance for bovine mastitis control and milk quality monitoring.

125 choice of the antibiotic to treat cows with mastitis could be determined based on the naked eye.

126 samples from women with laboratory-diagnosed mastitis (defined as elevated BM Na(+) levels) were 5.4-

127 ctly related to inflammation persistence and mastitis development.

128 An accurate, automated mastitis diagnosis tool has great potential to aid non-s

129 catalase in milk samples, a key indicator of mastitis disease in milk.

130 fied DNA of bacteria that are known to cause mastitis, DNA of bacteria that are known pathogens but h

131 ssociated with diseases of cattle, including mastitis, endocarditis, orchitis, and endometritis.

132 g a part in the changing pattern of clinical mastitis experienced in the modern dairy herd.

133 We hypothesized that mastitis facilitates the passage of HIV-1 from blood int

134 er; postpartum infections (puerperal sepsis, mastitis), fever, and malaria; and use of antibiotics du

135 inancial and animal welfare impact of bovine mastitis globally, improved tools are urgently needed th

136 Dairy cattle mastitis has long been one of the most common and costly

137 Current vaccines to Escherichia coli mastitis have shown some albeit limited efficacy.

138 I: 1.37, 8.54), and (for women with no prior mastitis history) using a manual breast pump (OR = 3.3,

139 Globally, 44 of 108 women (41%) developed mastitis; however, the percentage of women with mastitis

140 olecular regulatory mechanisms during bovine mastitis immune response and could lay the foundation fo

141 be an efficient method to prevent infectious mastitis in a susceptible population.

142 les with ST233 and ST234 have been linked to mastitis in animals.

143 Staphylococcus aureus is a major cause of mastitis in bovine and other ruminant species.

144 cteriophages that may be used for therapy of mastitis in cattle.

145 causes severe invasive disease in humans and mastitis in cattle.

146 Mastitis in dairy cattle is extremely costly both in eco

147 most important pathogens causing contagious mastitis in dairy cattle worldwide.

148 erichia coli is a leading cause of bacterial mastitis in dairy cattle.

149 . have become an important cause of clinical mastitis in dairy cows in New York State.

150 al pathogen of humans and a leading cause of mastitis in dairy cows worldwide.

151 ) H5N1 virus has been associated with severe mastitis in dairy cows, leading to decreased milk produc

152 aureus is a common causative agent of bovine mastitis in dairy herds.

153 solated from clinical and subclinical bovine mastitis in Egypt.

154 y pathogen causing pneumonia, arthritis, and mastitis in infected cattle.

155 with susceptibility to ketosis and clinical mastitis in Jersey and Holstein dairy cattle, respective

156 litis, progressive pneumonia, arthritis, and mastitis in sheep and goats.

157 Clinical mastitis in six Somerset dairy herds was monitored over

158 The frequency of mastitis in the collected milk samples was 48.4% (60/124

159 titis; however, the percentage of women with mastitis in the probiotic group (25% [n = 14]) was signi

160 y important in the epidemiology of S. uberis mastitis in the United Kingdom, with cow-to-cow transmis

161 for approximately 33% of all cases of bovine mastitis in the United Kingdom.

162 f Corynebacterium accolens and granulomatous mastitis in this patient is discussed.

163 until they stopped breastfeeding to describe mastitis incidence, mastitis treatment, and any associat

164 ved in the host defense of the udder against mastitis infection and that selective recruitment of the

165 esponses in the mammary gland during chronic mastitis infection.

166 Many cases of mastitis involve no known infectious agent and may funda

167 S. aureus-related bovine mastitis is a common reason for therapeutic and/or proph

168 Mastitis is a disease characterized by congestion, swell

169 Mastitis is a substantial clinical problem in lactating

170 Subclinical mastitis is a widely spread disease of lactating cows.

171 ssible role of anaerobic pathogens in bovine mastitis is also suggested.

172 Lactational mastitis is an excellent target to study possible intera

173 Dairy cow mastitis is an important disease in the dairy industry.

174 Mastitis is an inflammatory disease affecting mammary ti

175 Furthermore, the development of mastitis is closely linked to the exogenous pathway of t

176 Mastitis is known as intramammary inflammation, which ha

177 Mastitis is one of the most prevalent and costly disease

178 A critical step in the prevention of mastitis is the diagnosis of the predominant route of tr

179 Bovine mastitis is the most economically important infectious d

180 Mastitis is the most important bovine disease, causing d

181 cell line (MAC-T) by a Staphylococcus aureus mastitis isolate to study the potential role of intracel

182 Like a previously characterized bovine mastitis isolate, the standard laboratory strain, RN6390

183 fied in a pathogenicity island from a bovine mastitis isolate.

184 Although a significant number of mastitis isolates produce SAgs, the effect of these mole

185 In short, the onset of mastitis leads to changes in the microbiota and alterati

186 neumoniae strains isolated from dairy cattle mastitis milk in 11 U.S. states were sequenced.

187 Escherichia coli infection by using a mouse mastitis model.

188 pressed the LPS-induced immune response in a mastitis mouse model and that SAMC inhibited LPS-induced

189 ed breast milk sodium levels consistent with mastitis occurred in 16.4% of HIV-1-infected women and w

190 When mastitis occurred, the milk bacterial counts in the prob

191 itis treatment, and any associations between mastitis occurrence and hypothesized host characteristic

192 Inflammatory mastitis of unknown etiology includes the entities perid

193 ike pandemics and livestock diseases such as mastitis, often lead to unethical practices that comprom

194 ean wound infection, abdominopelvic abscess, mastitis or breast abscess, and other infections.

195 h Bovine spongiform encephalopathy, clinical mastitis or somatic cell count.

196 ipple thrush) in the same 3-week interval as mastitis (OR = 3.4, 95% CI: 1.37, 8.54), and (for women

197 cracks and nipple sores in the same week as mastitis (OR = 3.4, 95% CI: 2.04, 5.51), using an antifu

198 Mastitis, or inflammation of the breast, is associated w

199 clinical presentations in cattle, including mastitis, otitis, arthritis, and reproductive disorders.

200 The first mastitis outbreak was caused by a single strain of Klebs

201 We describe the occurrence of two Klebsiella mastitis outbreaks on a single dairy farm.

202 e involved in the response of the udder to a mastitis pathogen and if the type of mastitis pathogen i

203 er to a mastitis pathogen and if the type of mastitis pathogen influenced the subset composition of t

204 Control of the bovine mastitis pathogen Streptococcus uberis requires sensitiv

205 taphylococcus aureus is the major contagious mastitis pathogen, accounting for approximately 15-30% o

206 The mastitis pathogens identified by culture were generally

207 cussion centers around descriptions of novel mastitis pathogens in Streptococcaceae, Staphylococcacea

208 evealed alterations in the gut microbiota of mastitis rats characterized by an increased abundance of

209 evels of IFIH1, Tnfaip8l2, IRGM, and IRF5 in mastitis rats, which suggests that mastitis triggers an

210 reast-feeding (OR, 1.7; 95% CI, 1.0-2.9) and mastitis (relative risk [RR], 3.9; 95% CI, 1.2-12.7) wer

211 er, the underlying molecular pathogenesis of mastitis remains poorly understood.

212 Mastitis remains the most prevalent and costly disease t

213 As a first step toward enhancing mastitis resistance of dairy animals, we report the gene

214 ful biomarkers for the improvement of bovine mastitis resistance.

215 Duration of feeding was not associated with mastitis risk.

216 ted with increased transmission overall, and mastitis (RR, 21.8; 95% CI, 2.3-211.0) and breast absces

217 mphocytes in cows with S. aureus subclinical mastitis (SA group) and healthy controls (CK) were gener

218 Sub-acute mastitis (SAM) is a prevalent disease among lactating wo

219 cterial load was significantly higher in the mastitis samples and decreased after clinical symptoms d

220 ifferences were observed in culture-negative mastitis samples when compared to healthy milk.

221 itive benign lesions, such as: granulomatous mastitis, sclerosing adenosis, chronic inflammation, fat

222 result in both clinical (CM) or subclinical mastitis (SCM).

223 irulence factor of S. aureus associated with mastitis severity.

224 th significantly higher prevalence in bovine mastitis strains, compared to human-sourced or dairy env

225 resistance genes were identified in sporadic mastitis strains.

226 ide isolated from the cell envelop of bovine mastitis Streptococcus dysgalactiae 2023 is reported for

227 The chronic nature of bovine staphylococcal mastitis suggests that some products or components of S.

228 tic marker in the CXCR2 gene associated with mastitis susceptibility.

229 minate strains of S. uberis causing clinical mastitis that are likely to be responsive or unresponsiv

230 A second outbreak of Klebsiella mastitis that occurred several weeks later was caused by

231 li, Klebsiella spp. and Streptococcus uberis mastitis) the single most prevalent microorganism.

232 Mastitis, the most consequential disease in dairy cattle

233 85.7% of cases of recurrent quarter E. coli mastitis, the same genotype was implicated as the cause

234 ics are effective in the treatment of bovine mastitis, they do not address the regeneration of mammar

235 e valorization of whey from cows affected by mastitis, through a novel separation approach.

236 althy cows and cows with naturally occurring mastitis to determine if distinct alphabeta and gammadel

237 reastfeeding to describe mastitis incidence, mastitis treatment, and any associations between mastiti

238 d IRF5 in mastitis rats, which suggests that mastitis triggers an inflammatory response and immune st

239 Mastitis was defined as an elevated milk sodium (Na(+))

240 numbers observed in cows with streptococcal mastitis was due to a parallel increase in both CD4(+) a

241 The occurrence of mastitis was evaluated during the first 3 months after d

242 ollected from cows in August, 1998, although mastitis was evident among cows on the suspected farm.

243 requency in the same week or the week before mastitis was included in the model (for the same week: 7

244 Mastitis was not associated with compartmentalization by

245 inflammatory response; however, significant mastitis was observed 12 days after transduction.

246 Mastitis was present in 63 (15%) of 407, 60 (15%) of 407

247 served in milk from cows with staphylococcal mastitis was primarily due to increased numbers of CD4(+

248 Moreover, raw milk from cows with mastitis was tested successfully.

249 the acute host response to Escherichia coli mastitis, we analyzed gene expression patterns of approx

250 tion between microbiome diversity and bovine mastitis, we compared the microbiome of clinical mastiti

251 experiment modeling phage therapy for bovine mastitis, we observed pathogenicity island transfer betw

252 h confirmed staphylococcal and streptococcal mastitis were characterized by increased numbers of gamm

253 olved in recurrent cases of clinical E. coli mastitis were compared by DNA fingerprinting with entero

254 samples from women with (MW) or without (HW) mastitis were compared.

255 m cows with staphylococcal and streptococcal mastitis were due to a selective recruitment of a distin

256 y virus (HIV) type 1 load in breast milk and mastitis were examined as risk factors for vertical tran

257 very, HIV-1 load and sodium (an indicator of mastitis) were measured in breast milk from 334 HIV-1-in

258 acts as a prophylactic agent against bovine mastitis, which is a global agricultural problem.

259 t in a logistic regression model, history of mastitis with a previous child (odds ratio (OR) = 4.0, 9

260 f the nipple, previous treatment for Candida mastitis with oral or topical antifungals was ineffectiv

261 defined the changes occurring in SAU and NAS mastitis, with potential for improving detection (Proteo

262 eris is one of the leading pathogens causing mastitis worldwide.